domingo, 9 de enero de 2022

Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients - The Lancet Rheumatology

Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario